| SGOL | USL | SGOL / USL | |
| Gain YTD | 0.097 | 57.214 | 0% |
| Net Assets | 7.38B | 52.5M | 14,055% |
| Total Expense Ratio | 0.17 | 1.01 | 17% |
| Turnover | N/A | N/A | - |
| Yield | 0.00 | 0.00 | - |
| Fund Existence | 17 years | 19 years | - |
| SGOL | USL | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Stochastic ODDS (%) | 4 days ago 84% | 4 days ago 89% |
| Momentum ODDS (%) | 4 days ago 74% | 4 days ago 82% |
| MACD ODDS (%) | 4 days ago 58% | 4 days ago 78% |
| TrendWeek ODDS (%) | 4 days ago 70% | 4 days ago 87% |
| TrendMonth ODDS (%) | 4 days ago 69% | 4 days ago 86% |
| Advances ODDS (%) | 11 days ago 83% | 6 days ago 87% |
| Declines ODDS (%) | 13 days ago 67% | 4 days ago 82% |
| BollingerBands ODDS (%) | 4 days ago 90% | N/A |
| Aroon ODDS (%) | 4 days ago 52% | 4 days ago 86% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PVETX | 16.87 | N/A | N/A |
| PACE Small/Medium Co Val Eq P2 | |||
| SUIIX | 71.81 | -1.18 | -1.62% |
| DWS CROCI International Inst | |||
| WAYFX | 20.06 | -0.47 | -2.29% |
| Waycross Focused Core Equity Fund | |||
| ETAHX | 46.52 | -1.35 | -2.82% |
| Eventide Healthcare & Life Sciences A | |||
| BMGAX | 30.89 | -1.31 | -4.07% |
| BlackRock Mid-Cap Growth Equity Inv A | |||